Experience Matters

Previously, Samantha served as Director of Sustainability and Product Stewardship at Medtronic, where she established a pioneering Sustainability R&D organization and led the development of the company's first externally reported product and packaging sustainability goals.

Her career includes leadership positions at Honeywell, Procter & Gamble, BIC Consumer Products, Energizer, and Medtronic. She is also the Founder and Principal Consultant of KeeneySmith Consulting LLC and holds a Bachelor of Science in Packaging Science from Michigan State University.

A Quinnipiac University accounting graduate and Certified Public Accountant, he has spent the past decade focused primarily on startups and early-stage companies, helping build organizations, develop growth strategies, secure capital, and establish the financial infrastructure needed to scale.

He has also served as a consultant to early- and mid-stage life science companies, working closely with senior leaders and boards to provide strategic financial guidance and support key business milestones.  Previously, Michael served as Executive Vice President and CFO of Invea Therapeutics and Corporate Controller of SurgiQuest, supporting its successful exit to CONMED Corporation. 

He brings a hands-on, growth-oriented approach to financial strategy, capital planning, business execution, and partnering with leadership teams to create long-term value.

Gary has worked in the healthcare and medical device industry since 1981, including fifteen years as a senior executive in four private equity-backed ventures.

Gary began his career in healthcare with United States Surgical, where he spent 22 years in commercial-facing roles, including Vice President of Sales Operations and Distribution Sales for Tyco Healthcare following the acquisition of USS.

Gary served as Executive Vice President of Sales and Marketing at Accellent, where he led the Sales and Marketing strategy through the acquisition and integration of MedSource Technologies and led the re-branding of the combined organization through its acquisition by Kohlberg, Kravis, and Roberts in 2005.

Gary then joined THP’s portfolio company Interface Catheter Solutions, as President and CEO. He led strategic growth into contract manufacturing and through the acquisition by NDC/Confluent Medical. Gary was President of Trelyst, focused on developing silicone-based combination drug-delivery devices and acquired by Avantor in 2016.

Gary has served as a Venture Partner for Telegraph Hill Partners since 2017 and has represented THP on the boards of Medpricer as Executive Chairman, Argonaut Manufacturing Services, Dynex Technologies, InvisALERT, and Emerging Therapy Solutions.

Tom's accomplishments speak to his ability to navigate complex challenges and drive innovation in the medical device industry. At RevMedica, Tom leads the development of a novel, handheld robotic solution intended to optimize clinical decision-making and improve patient safety with a cost-effective and environmentally friendly surgical system.

Under his leadership, RevMedica has amassed a robust patent portfolio, assembled a team of key advisers, and successfully demonstrated the feasibility of RevMedica’s core design. Tom’s visionary leadership extends beyond product development.

He has played a pivotal role in shaping RevMedica's strategic direction, building a talented team, and securing funding to support the company's growth. His hands-on approach to every aspect of the business underscores his dedication to ensuring the success of RevMedica.

With a career spanning over two decades, Steve has held key roles in various industries, demonstrating a consistent drive for growth and innovation.

Most recently, Steve served as Vice President of Strategy and Corporate Development at Prosidyan, Inc., where he played a pivotal role in a successful exit in 2022. Since then, he has consulted with several companies helping to develop and refine their go-to-market strategy.

His extensive experience also includes leadership positions at United States Surgical Corporation, Johnson & Johnson/DePuy Synthes Spine, and Paradigm Spine, LLC.

Joe is an expert in Quality Assurance and has diverse experience from his involvement in all phases of product lifecycle for many disposable and reusable medical devices, both from Covidien (Medtronic) as well as others.

Joe always holds patient safety at the center of his focus and has followed the pursuit of improving clinical outcomes throughout his career.

Rob worked as a strategy consultant for a total of 10 years, partnering with emerging biotechnology and medical technology companies as well as large, global organizations to inform key decisions on clinical development, launch strategy, market development, brand lifecycle strategy, and promotional campaign development.

Prior to working as a strategy consultant, Rob worked at Telegraph Hill Partners for four years as an Associate, working on market analysis, transaction execution, and portfolio company initiatives.

Prior to working as an Associate at Telegraph Hill Partners, Rob worked as an analyst at Seven Hill Partners, a boutique investment banking firm focused on life sciences and technology verticals. Rob represents THP on the boards of Cell Microsystems and Emerging Therapy Solutions.

Rob holds a BBA in Finance from the University of Notre Dame and an MBA with honors from UC Berkeley’s Haas School of Business.

He brings extensive global concept-to-commercialization expertise, having launched numerous disruptive and transformational medical technologies. Ron previously served as Chief Commercial Officer of Standard Bariatrics, Inc., where he led commercialization, market development, and scale-up activities for the company’s revolutionary stapling technology in bariatric surgery. Under his leadership, the company achieved significant growth in market value, culminating in its acquisition by Teleflex Incorporated for $300 million.

Most recently, Ron transitioned from full-time executive service as Vice President of Sales and Marketing at GT Metabolic Solutions, where he led the commercialization of the company’s transformational magnetic compression anastomosis technology throughout the North American market. Ron holds a Bachelor of Science degree in Economics and Marketing from Indiana University of Pennsylvania.

Tim has been investing in private equity since joining the Schroder Ventures US operation in 1984. He went on to form Collinson Howe Venture Partners (“CHVP”) in 1990, which has managed multiple funds under the names CHL Medical Partners, Biotechnology Investment Group LLC, and HealthInvest Equity Partners, L.P.

He has served on over 30 private and public corporate boards. Tim is a graduate of Columbia College and the Columbia Graduate School of Business, where he was an Adjunct Assistant Professor for 17 years teaching Venture Capital Management.

Robert has a proven record of building teams and companies from concept through commercialization and successful exit. He is an EY Entrepreneur of The Year™.

Robert is currently the Executive Chairman of Fifth Eye Medical and an Operating Partner at Havencrest Healthcare Partners. He also serves as a Non-Executive Board Director at TSC Life and Synopsis Medical, and a strategic adviser to Creo Medical and Rhaeos. Robert founded, built, and led Medivance, Inc. (acquired by BD) and Virocyt, Inc. (acquired by Sartorius) to successful exits as well as Bolder Surgical (acquired by Hologic), for which he was Chairman and CEO.

Robert has held senior management positions at Pfizer and Covidien and earned an MBA from the University of Colorado, an MS in Microbiology from the University of Illinois, and a BA in chemistry from Colorado College.